International audienceIn this paper, we numerically investigate the fluorescence decay of Tm-doped tellurite glasses with different dopant concentrations. The aim is to find a set of data that allows the prediction of material performance over a wide range of doping concentrations. Among the available data, a deep investigation of the reverse cross-relaxation process (3 F 4 , 3 F 4 ,→ 3 H 6 , 3 H 4) was not yet available. The numerical simulation indicates that the reverse cross-relaxation process parameter can be calculated by fitting the slow decaying 3 H 4 fluorescence tails emitted when the pump level is almost depopulated. We also show that the floor of the 3 H 4 decay curve is indeed related to a second exponential constant, half the 3 F 4 lifetime, kicking in once the 3 H 4 level depopulates. By properly fitting the whole set of decay curves for all samples, the proposed value for the reverse cross-relaxation process is 0.03 times the cross-relaxation parameter. We also comment on the measurement accuracy and best setup. Excellent agreement was found between the simulated and experimental data, indicating the validity of the approach. This paper therefore proposes a set of parameters validated by fitting experimental fluorescence decay curves of both the 3 H 4 and 3 F 4 levels. To the best of our knowledge, this is the first time a numerical simulation has been able to predict the fluorescence behavior of glasses with doping levels ranging from 0.36 mol% to 10 mol%. We also show that appropriate calculations of the reverse cross-relaxation parameter may have a significant effect on the simulation of laser and amplifier devices
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.